/Investor DB

Arcadian Capital — Full Portfolio

4 tracked investments · listed companies and verified rows first

Front Range BiosciencesinSep 2019 · $8.5M

US-focused tissue culture cloning and biotech.

Boulder, US

Christopher Zalewski(Founder)inJonathan Vaught(Founder)inNick Hofmeister(Founder)

Co-investorsKEY Investment PartnersAFI Capital PartnersHALLEY Venture PartnersMilitello CapitalNew York AngelsPhyto Partners+2 more

Fyllofyllo.inin𝕏Nov 2021 · $40M

Fyllo builds IoT sensor devices, hyper-local weather forecasting, and crop-specific agronomy models that provide data-driven irrigation, fertigation, and disease-prediction recommendations to farmers.

AgTechAI & Machine LearningIoTBengaluru, IN

Sudhanshu Rai(Co-Founder)inSumit Sheoran(Co-Founder)in

Co-investors100XCapria VenturesIndia QuotientTitan CapitalAmbria CapitalPhyto Partners+1 more

KadenwoodinJun 2021 · $50M

Newport Beach, US

Todd Davis(Manager, Chairman)inErick Dickens(Manager, CEO)Doug Weekes(Manager, COO)

BoardJonathan Christodoro(Manager)Glen Russell(Manager)

Co-investorsThe Craftory

Meadowgetmeadow.comin𝕏Seed

Meadow provides software for cannabis dispensaries, offering inventory management, compliance automation, and reporting tools.

Enterprise SoftwareRetail TechSaaSSan Francisco, US

David Hua(Founder)inRick Harrison(Founder)inScott A Garman(Founder)inHarrison Lee(Founder)inAlfredo Brillembourg(Founder)Amy Jenkins(Founder)

Co-investorsPioneerSoma CapitalY CombinatorAlleyCorpBBQ CapitalDominion Capital+17 more

Petalfastpetalfast.comMay 2021 · $2.8M

Petalfast provides sales, field, and trade support for cannabis brands and retailers, handling sell-in along with budtender trainings, in-store demos, and merchandising.

Retail TechSaaSSales TechIrvine, US

Jason Vegotsky(Executive Officer, Director)Arun Kurichety(Executive Officer, Director)inArmon Vakili(Director)

BoardRyan Moses(Director)Jennifer Hildebrandt(Director)James English(Director)

Co-investorsMerida Capital HoldingsWGD Capital, L.P.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.